Very excited to join fellow investors AQC Capital Capital, Anges Québec Québec and BDC Capital (Canada) (Canada) and 19 other US and Canadian investors to support Hexoskin in their next phase of development globally 🌎 Impressive quality device and wealth of data gathered over the years in field of cardiology, respiratory and rare disease. Coupled with strong AI capabilities 🧬 Lots of opportunities in field of prevention and disease management. Very promising for patients #digitalhealth #patientcare Laurent van Lerberghe
CEO at Hexoskin - Wearable Health Sensors, Clinical AI & Digital Biomarkers - Mayo Clinic Accelerator Alumni
Very happy to share the news that Hexoskin has raised an additional $4.2M to invest in digital biomarkers research and AI-based diagnostics! I'd like to thank our partners from AQC Capital, Anges Québec, BDC Capital (Canada), ballas invest (Europe), Deep Divers Ltd (UK), and 19 other US and Canadian investors for supporting our mission during these last few years when raising capital was challenging for most. A special thanks to Laurent van Lerberghe, Co-Founder of ballas invest and former Chief Strategy Officer at Sanofi for joining this round as an investor and advisor! Hexoskin’s team has over 15 years of experience in clinical AI development and high-resolution wearable sensors. Our partners understand how our digital platform is uniquely positioned to develop a range of diagnostic tests and digital solutions to address the needs of patients with cardiac, respiratory, neurological, and rare diseases. Over the past 10 years, Hexoskin has built the largest ambulatory cardio-respiratory database in the world. The database includes hundreds of millions of breathing patterns and billions of cardiac rhythm patterns, in addition to sleep data and annotations specific to many other health conditions, developed with hospitals and research partners in the US, Canada, and Europe. It's been quite a journey since we started developing our first wearable sensors more than 15 years ago. Today we can finally say we have an end-to-end software solution for clinical research to serve our clients, from space medicine to Ivy League research labs, from pediatric research to research on aging. Our selection in the first cohort of the Mayo Clinic and ASU MedTech Accelerator program in 2019 confirmed our position as a global leader in health innovation. More information about the investment on our website: https://lnkd.in/gMNQwKGx Carré Technologies Inc., HITLAB, MEDTEQ+, Arizona BioIndustry Association (AZBio), Southern California Biomedical Council (SoCalBio), BIOQuebec, Montréal InVivo, Canadian Space Agency | Agence spatiale canadienne, Trade Commissioner Service | Service des délégués commerciaux, Frédéric Lovighi, Le Chiffre, YULEX, avocats et stratèges, s.e.n.c.r.l., KPMG #AI #clinicaltrials #medical #wearables #digitalbiomarkers #vc #angel #medtech #funding #startups #saas #digitalhealth #datascience
